Your prediction
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -1.040% | 17.138% | 35.152% | -54.422% | 40.946% | -43.580% | -92.777% |
| Pacira Pharmaceuticals | -0.580% | 4.217% | -19.907% | -20.642% | -19.907% | -49.415% | -69.107% |
| Twist Bioscience Corp | -1.090% | 2.316% | 24.582% | -30.524% | 28.474% | 39.357% | -73.299% |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat
